SCHEMBL28025218

SCHEMBL28025218

CC(=O)Oc1cnnc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 2/20 0.41
ALDH1A1 P00352 1/20 0.41
F2 P00734 1/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 3/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 2/20 0.35
POLB P06746 2/20 0.35
PKM P14618 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ACHE P22303 2/20 0.35
MEN1 O00255 1/20 0.35
TTR P02766 1/20 0.35
TP53 P04637 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ELANE P08246 1/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
BACE1 P56817 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11193601 0.87 MAPT (0.30) MAPTKMT2A
SCHEMBL28024734 0.78 GLA (0.41) GLAALDH1A1F2HPGDLMNA
SCHEMBL28025226 0.74 ALDH1A1 (0.38) GLAALDH1A1F2HPGDLMNA
SCHEMBL28025233 0.73 HDAC4 (0.39) GLAALDH1A1F2HPGDLMNA
SCHEMBL30973576 0.71 LMNA (0.47) ALDH1A1HPGDLMNAMAPTKDM4E
SCHEMBL2860423 0.70 LMNA (0.46) GLAALDH1A1F2HPGDLMNA
SCHEMBL361444 0.70 ALDH1A1 (0.47) GLAALDH1A1F2HPGDLMNA
SCHEMBL27448841 0.70 LMNA (0.42) GLAALDH1A1F2HPGDLMNA
SCHEMBL6583226 0.69 GLA (0.46) GLAALDH1A1F2HPGDLMNA
SCHEMBL21612934 0.68 ALDH1A1 (0.45) GLAALDH1A1F2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105452233-A Piperidine and azepane derivatives as prokineticin receptor modulators TAKEDA PHARMACEUTICALS CO 2016-03-30 CN disclosed
CN-105143209-A Biaryl amide compounds as kinase inhibitors NOVARTIS AG 2015-12-09 CN disclosed